Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001390478-25-000003
Filing Date
2025-03-20
Accepted
2025-03-20 16:01:19
Documents
92
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K sls-20241231.htm   iXBRL 10-K 1882973
2 EX-10.9 sls-20241231ex109.htm EX-10.9 15323
3 EX-10.11 sls-20241231ex1011.htm EX-10.11 41224
4 EX-10.12 sls-20241231ex1012.htm EX-10.12 12637
5 EX-10.13 sls-20241231ex1013.htm EX-10.13 12802
6 EX-14.1 sls20241231ex141.htm EX-14.1 85510
7 EX-19.1 sls-20241231ex191.htm EX-19.1 64856
8 EX-21.1 sls20241231ex211nextgen.htm EX-21.1 4272
9 EX-23.1 sls20241231ex231nextgen.htm EX-23.1 2435
10 EX-31.1 sls20241231ex311nextgen.htm EX-31.1 8303
11 EX-31.2 sls20241231ex312nextgen.htm EX-31.2 8281
12 EX-32.1 sls20241231ex321nextgen.htm EX-32.1 8890
18 image1.jpg GRAPHIC 26680
19 sls-20241231_g1.jpg GRAPHIC 30719
20 sls-20241231_g2.jpg GRAPHIC 377301
21 sls-20241231_g3.jpg GRAPHIC 824153
22 sls-20241231_g4.jpg GRAPHIC 31312
23 sls-20241231_g5.jpg GRAPHIC 53247
24 sls-20241231_g6.jpg GRAPHIC 205583
25 sls-20241231_g7.jpg GRAPHIC 166676
26 sls-20241231_g8.jpg GRAPHIC 667284
  Complete submission text file 0001390478-25-000003.txt   12999644

Data Files

Seq Description Document Type Size
13 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sls-20241231.xsd EX-101.SCH 45790
14 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sls-20241231_cal.xml EX-101.CAL 58268
15 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sls-20241231_def.xml EX-101.DEF 144553
16 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sls-20241231_lab.xml EX-101.LAB 571042
17 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sls-20241231_pre.xml EX-101.PRE 382662
95 EXTRACTED XBRL INSTANCE DOCUMENT sls-20241231_htm.xml XML 681573
Mailing Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036
Business Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036 6462005278
SELLAS Life Sciences Group, Inc. (Filer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33958 | Film No.: 25756358
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)